Lantern Pharma Inc. Current Liabilities
Lantern Pharma Inc. (LTRN) had Current Liabilities of $4.32 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $4.32M.
- 2026-03-31: Liabilities, Current $3.78M.
- 2025-12-31: Liabilities, Current $4.50M.
- 2025-09-30: Liabilities, Current $4.04M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $4.32M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.78M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $4.50M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $4.04M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.88M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.29M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.33M 10-K · filed 2026-03-30 |
| 2024-09-30 | $3.60M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $4.60M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.95M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.68M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.25M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $3.02M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.79M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.80M 10-K · filed 2024-03-18 |
| 2022-09-30 | $3.14M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $5.30M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $3.07M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $2.33M 10-K · filed 2023-03-20 |
| 2021-09-30 | $1.79M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $2.69M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $664.53K 10-Q · filed 2021-05-03 |
| 2020-12-31 | $552.34K 10-K · filed 2022-03-10 |
| 2020-09-30 | $814.56K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $2.28M 10-Q · filed 2020-07-30 |
| 2019-12-31 | $489.29K 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |